Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03614949
Title SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

cervical cancer

Therapies

Atezolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.